| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.41 | 0.007 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |